Search consultations



Proposal to amend listings in the National Immunisation Schedule

PHARMAC  is consulting on proposed changes to the NIS affecting: 

  • Pneumococcal conjugated (PCV13) vaccine;
  • Varicella vaccine; Haemophilus influenzae type B (Hib) vaccine; 
  • transition period for Brand switches and introduction of  Pneumococcal (PCV10) vaccine (Synflorix), Measles, mumps and rubella vaccine (Priorix),  Haemophilus influenzae type B vaccine (Hiberix); and Rotavirus vaccine (Rotarix);
  • Minor clarifications to special authority criteria for Hepatitis B recombinant vaccine and Pneumococcal (PPV23) polysaccharide vaccine; and
  • Tuberculin purified protein derivative (Mantoux) test

Feedback due: Please send feedback to  by 13 January 2017.

Read or Download

Notify me when this page changes

Enter your email address below to receive alerts when this page is updated.

Sign up below to receive an email when we update this page

Enter the code shown above in the box below.